Physician profile
Jonathan J Dorn
NPI 1154327435
$1,954.07
in general payments reported to CMS, 2019-2025
17 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $213 · 2020: $95.25 · 2021: $467 · 2022: $386 · 2023: $228 · 2024: $225 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $775 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $774.88 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $280.92 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $245.85 | 2022-2025 | Tyrvaya, Ryzumvi |
| Mallinckrodt Hospital Products INC. | $202.63 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $191.45 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Kala Pharmaceuticals, INC. | $165.97 | 2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $147.59 | 2019-2021 | |
| Alcon Vision LLC | $145.06 | 2021-2025 | Rocklatan, Clareon, Tryptyr |
| Abbvie INC. | $137.36 | 2019-2025 | |
| Allergan, INC. | $136.40 | 2019-2022 | |
| Aerie Pharmaceuticals, INC. | $66.36 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $56.16 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $50.78 | 2022 | |
| Thea Pharma INC. | $38.89 | 2023-2025 | Iyuzeh |
| Dompe US, INC. | $35.73 | 2024-2025 | Oxervate |
| Novartis Pharmaceuticals Corporation | $26.81 | 2019-2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $13.16 | 2019 | |
| Rayner Intraocular Lenses Limited | $12.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Dorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.